Literature DB >> 6190014

Vesicular stomatitis virus mutant with altered polyadenylic acid polymerase activity in vitro.

D M Hunt.   

Abstract

In vitro RNA synthesis by purified virions of a stock of tsG16(I) was aberrant compared with that of wild-type (wt) vesicular stomatitis virus. RNA made in vitro by tsG16(I) contained a larger proportion of A residues in polyadenylic acid [poly(A)] tracts than did RNA synthesized by wt virus, tsG13(I), tsG21(II) or tsG41(IV). Experiments to determine whether the aberrant polyadenylation was correlated with the known thermolability of the tsG16(I) L protein were inconclusive. Total product RNA made by tsG16(I) was methylated to almost the same extent as wt RNA, contained the same major methylated 5' cap structure as wt RNA, and was translated as well in a reticulocyte cell-free system, yielding the same molecular weight proteins in similar ratios. Most polyadenylated [poly(A)+] RNA made by tsG16(I) was considerably larger than wt poly(A)+ RNA and richer in AMP:UMP residues; however, the protein-coding capacities of mutant and wt poly(A)+ RNAs were similar. This suggested that most mRNAs made in vitro by tsG16(I) might possess very long poly(A)+ tracts, and digestion of RNA by T1 RNase supported this. It appeared, therefore, that a virally coded component of vesicular stomatitis virus could affect polyadenylation. This could be the poly(A) polymerase itself, a protein involved in control of polyadenylation, or a protein which affects an event spatially and temporally connected with polyadenylation (such as initiation of the subsequent mRNA).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190014      PMCID: PMC256555     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus.

Authors:  L P Villarreal; J J Holland
Journal:  Nat New Biol       Date:  1973-11-07

2.  In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  A K Banerjee; D P Rhodes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

3.  Location of the transcription defect in group I temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  D M Hunt; R R Wagner
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

4.  Effect of temperature-sensitive mutations on the virion-associated RNA transcriptase of vesicular stomatitis virus.

Authors:  J F Szilágyi; C R Pringle
Journal:  J Mol Biol       Date:  1972-11-14       Impact factor: 5.469

5.  Studies on the in vitro adenylation of RNA by vesicular stomatitis virus.

Authors:  A K Banerjee; S A Moyer; D P Rhodes
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

6.  Synthesis of viral mRNA and polyadenylate by a ribonucleoprotein complex from extracts of VSV-infected cells.

Authors:  M F Murphy; R A Lazzarini
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

7.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

10.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

View more
  10 in total

Review 1.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

Review 2.  Regulation of mRNA polyadenylation-deadenylation.

Authors:  C M Tsiapalis
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

3.  Aberrant polyadenylation by a vesicular stomatitis virus mutant is due to an altered L protein.

Authors:  D M Hunt; E F Smith; D W Buckley
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

Review 4.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

5.  Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.

Authors:  Jianrong Li; John S Chorba; Sean P J Whelan
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome.

Authors:  Zackary W Whitlow; John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis.

Authors:  Jianrong Li; Amal Rahmeh; Vesna Brusic; Sean P J Whelan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein.

Authors:  Summer E Galloway; Gail W Wertz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  New mRNAs are preferentially translated during vesicular stomatitis virus infection.

Authors:  Zackary W Whitlow; John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein.

Authors:  Summer E Galloway; Paul E Richardson; Gail W Wertz
Journal:  Virology       Date:  2008-10-11       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.